Skip to main content
. 2019 Feb 11;40(1):693–699. doi: 10.1080/0886022X.2018.1491405

Table 2.

Comparison between survivors and non-survivors.

Characteristics Survivors (30) Non-survivors (16) p Value
Age (yr) 49.23 ± 10.48 50.50 ± 8.56 .680
Male/female, n (%) 25/5 (83.3) 15/1 (93.8) .318
Initial systolic blood pressure (mm/Hg) 108.57 ± 33.67 110.06 ± 35.28 .888
Inotropic support at admission, n (%) 11 (36.7) 12 (75.0) .029
Need for mechanical ventilation, n (%) 7 (24.1) 11 (68.8) .005
Need for renal replacement therapy, n (%) 6 (20.0) 8 (50.0) .048
AKI, n (%) 24 (80.0) 15 (93.8) .464
 Risk 4 (16.7) 5 (33.3)  
 Injury 6 (25.0) 5 (33.3)  
 Failure 14 (58.3) 5 (33.3)  
Acute pancreatitis (%) 6 (20.7) 4 (25.0)  
Total LODS score 5.13 ± 4.04 8.56 ± 4.49 .011
Probability of mortality based on the LODS score (%) 28.08 ± 27.20 52.61 ± 32.65 .009
Arterial pH 7.01 ± 0.22 6.89 ± 0.27 .115
Bicarbonate (mmol/L) 4.73 ± 3.12 5.31 ± 4.39 .606
BUN (mmol/L) 30.82 ± 21.48 27.51 ± 15.92 .591
Ceatinine (mmol/L) 2.32 ± 1.73 2.17 ± 1.19 .749
Lactate (mmol/L) 13.05 ± 9.21 16.12 ± 7.46 .315
Serum anion gap (AG) (mmol/L) 40.46 ± 10.29 35.49 ± 9.14 .112
Corrected AG (mmol/L) 40.85 ± 9.84 37.51 ± 9.44 .273
Prothrombin activity (%) 64.10 ± 19.94 47.69 ± 20.10 .012
Total bilirubin 1.71 ± 1.19 2.06 ± 0.51 .371
White blood cell (x103/mm3) 9.70 ± 9.33 16.48 ± 16.13 .077
Hemoglobin (g/dL) 12.96 ± 3.05 12.06 ± 2.23 .308
Platelet (×103/mm3) 210.20 ± 102.26 119.75 ± 85.10 .004
Albumin (g/dL) 3.86 ± 0.83 3.19 ± 0.93 .017
Amylase (U/L) 157.56 ± 183.68 409.80 ± 674.88 .073
Lipase (U/L) 90.89 ± 120.47 144.00 ± 190.77 .275
LDH (IU/L) 501.69 ± 598.44 1520.52 ± 380.13 .018
CRP (mg/L) 18.26 ± 38.69 24.66 ± 49.81 .654

LODS: Logistic organ dysfunction system.